Odyssey Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Odyssey Therapeutics, Inc. - overview
Established
2021
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2021 by Eicke Latz, Kim Lewis, Felix Meissner, and Florian Schmidt, Odyssey Therapeutics Inc. develops anti-inflammation immunotherapies to treat inflammatory diseases and cancer. As of February 2024, Gary D. Glick is the CEO of the company.
In May 2026, Odyssey Therapeutics, Inc. raised USD 279 million in an IPO, selling 15. 5 million shares at USD 18 per share, within the expected USD 16-18 range, on the Nasdaq Global Select Market under the ticker symbol "ODTX. " Odyssey Therapeutics, Inc.
has granted the underwriters a 30-day option to purchase up to an additional 2. 33 million shares of common stock as part of the listing. Following the transaction, SR One retained a 6. 8% minority stake, OrbiMed Advisors retained a 5.
8% minority stake, Fidelity Investments retained a 5. 3% minority stake, Jeito Capital retained a 4. 9% minority stake, TPG retained a 4. 9% minority stake, Lightspeed Venture Partners retained a 4.
7% minority stake, and Dimension Capital Management retained a 4. 7% minority stake in Odyssey Therapeutics, Inc. , respectively. Odyssey Therapeutics Inc.
develops novel therapeutics for patients with autoimmune diseases using modern machine-learning techniques. Its offerings include immunomodulators, oncology medicines, and many others.
Current Investors
OrbiMed Advisors, Colt Ventures, HBM Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.odysseytx.com
Verticals
Artificial Intelligence
Company Stage
Mature
Total Amount Raised
Subscriber access only
Odyssey Therapeutics, Inc. - employee data
Odyssey Therapeutics, Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman Of The Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.